Human Molecular Genetics Advance Access originally published online on August 18, 2007
Human Molecular Genetics 2007 16(21):2626-2639; doi:10.1093/hmg/ddm219
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Isolation and characterization of the Drosophila ubiquilin ortholog dUbqln: in vivo interaction with early-onset Alzheimer disease genes
1 Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Diseases, Department of Neurology, Massachusetts General Hospital and Harvard Medical school, Charlestown, MA, USA, 2 Department of Anesthesia and Critical Care, Massachusetts General Hospital and Harvard Medical school, Charlestown, MA, USA and 3 Program in Membrane Biology, Massachusetts General Hospital and Harvard Medical school, Charlestown, MA, USA
* To whom correspondence should be addressed: Genetics and Aging Research Unit, MGH-East (MIND), 114 16th Street, Charlestown, MA 02128, USA. Tel: +1 6177266845; Fax: +1 6177241823; Email: tanzi{at}helix.mgh.harvard.edu
Received June 29, 2007; Accepted August 3, 2007
UBQLN1 variants have been associated with increased risk for late-onset Alzheimers disease (AD). We produced transgenic Drosophila models that either silence (by RNAi) or overexpress the Drosophila ortholog of human UBQLN1, dUbqln. Silencing of dUbqln in the central nervous system led to age-dependent neurodegeneration and shortened lifespan. Silencing of dUbqln in the wing led to wing vein loss that could be partially rescued by mutant rhomboid (rho), a known component of epidermal growth factor receptor signaling pathway. Conversely, overexpression of dUbqln promoted ecotopic wing veins. Overexpression of dUbqln in the eye rescued a small, rough eye phenotype induced by overexpression of Drosophila presenilin (dPsn), and also rescuing dPsn-induced malformations in bristles. In contrast, RNAi silencing of dUbqln enhanced the retinal degenerative defect induced by overexpression of dPsn. Finally, co-overexpression of dUbqln and the human amyloid precursor protein (APP) in the eye significantly reduced the levels of full-length APP and its C-terminal fragment. Collectively, these data support in vivo functional interaction between UBQLN1 and the AD-associated genes, presenilin and APP, and provide further clues regarding the potential role of UBQLN1 in AD pathogenesis.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. J. Lim, R. Danner, J. Liang, H. Doong, C. Harman, D. Srinivasan, C. Rothenberg, H. Wang, Y. Ye, S. Fang, et al. Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD J. Cell Biol., October 19, 2009; 187(2): 201 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ganguly, R.M. R. Feldman, and M. Guo ubiquilin antagonizes presenilin and promotes neurodegeneration in Drosophila Hum. Mol. Genet., January 15, 2008; 17(2): 293 - 302. [Abstract] [Full Text] [PDF] |
||||

